Mitsu Chem Plast Limited (Mitsu), one of the leading global manufacturers of Blow moulded & Injection Moulded products, celebrated 35 years of excellence and innovation, and announced a strategic plan to achieve Rs. 1,000 crore in annual revenue by 2028. This goal represents a threefold increase over the company's FY24 topline within four years.

Reflecting on the roadmap ahead, Jagdish Dedhia, Chairman of Mitsu Chem Plast Limited said, "Setting our sights on the ₹1,000 Cr milestone by 2028 is a natural extension of Mitsu Chem Plast's 35-year legacy of innovation and customer focus. This ambition isn't just about scaling revenues it's about deepening our impact in the healthcare products, where Furnastra's advanced polymer solutions can improve patient care worldwide.

To get there, we are doubling down on our four growth pillars: driving operational efficiency through lean, waste-free processes; executing data-led marketing to forge stronger customer relationships; selecting products with rigorous scientific validation; and empowering our people with continuous learning and accountability.

All of this will be underpinned by sustainable manufacturing practices-minimizing our carbon footprint, conserving resources and embracing circular-economy initiatives-so that our growth is both profitable and planet-positive."

The company will significantly expand its Hospital Furniture division under the renowned Furnastra brand-adding advanced, design-forward solutions to modern era. It will significantly expand its Packaging division Through Expansion in Pails, Blow Moulded Container and Specialised caps & Closure.

Mitsu is set to build an operational model that champions both efficiency and consistency by refining manufacturing processes, reducing waste, and enhancing speed and quality. The company is further strengthening customer engagement and fostering lasting brand loyalty in both domestic and global markets.

With robust R&D and meticulous market analysis, Mitsu will introduce state-of-the-art products that meet the evolving demands of healthcare-delivering clear economic benefits.